Stay updated on Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    - Added a government-operating-status notice and a current operating status link, and - updated the revision version from v3.1.0 to v3.2.0. No other substantive content changes were detected.
    Difference
    2%
    Check dated 2025-10-07T20:38:46.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Updated the page from Revision: v3.0.2 to Revision: v3.1.0, signaling a new software version.
    Difference
    0.0%
    Check dated 2025-09-30T00:15:26.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Page revision updated to v3.0.2 and Back to Top UI element removed.
    Difference
    0.1%
    Check dated 2025-09-14T18:54:09.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-09-07T13:39:08.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The web page has been updated to include a new facility name and location, as well as specific details about a clinical trial involving pembrolizumab and cabozantinib for renal cell carcinoma. Notably, previous mentions of clear cell renal cell carcinoma and various pharmacological terms have been removed.
    Difference
    3%
    Check dated 2025-08-31T11:36:24.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.0%
    Check dated 2025-08-17T01:47:09.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial page.